by Truveta Staff | Nov 18, 2022 | News, Research
Last week, two members of Truveta Research — Dr. Charlotte Baker, DrPH, MPH, CPH, and Dr. Peter Smits, PhD — attended the 150th Annual Meeting of the American Public Health Association (APHA) in Boston. Dr. Peter Smits presented on Truveta Research’s...
by Truveta Research | Nov 2, 2022 | Research, Research Insights
UPDATE 1/11/2023: The analysis in this blog has been published as a part of a peer-reviewed paper in Frontiers in Public Health: Racial inequality in COVID treatment and in-hospital length of stay in the US over time. Many researchers have goals to conduct novel...
by Truveta Research | Oct 4, 2022 | Research, Research Insights
Peripheral Artery Disease (PAD) is a common disease that causes the arteries in the extremities to narrow. Recently, as part of PAD Awareness Month, we investigated disparities in the frequency of common procedures used to treat PAD, known as endovascular (or...
by Truveta Research | Sep 27, 2022 | Research, Research Insights
Peripheral artery disease (PAD) is a common disease that causes narrowing of the arteries in the extremities. The lifetime risk for Americans varies between 19-30% [1]. Many studies have shown that PAD disproportionately affects both Black or African American...
by Truveta Research | Sep 22, 2022 | Research, Research Insights
Early in the pandemic, very little was known about the best treatment pathways for COVID-19, and there were no approved drug therapies available. Doctors were quoted saying, “To be honest, we didn’t know [how to treat patients]” [1]. The first approved COVID...
